Business / Corporate | FOCUS May 9, 2018
Challenges await Takeda after $62 billion Shire victory
Takeda Pharmaceutical Co.'s Chief Executive Officer Christophe Weber navigated rebuffs, critics and a plunging stock price to win a $62 billion (¥6.8 trillion) deal to acquire larger rival Shire Plc. Integrating the Japanese drugmaker — which began by selling herbal therapies 237 years ago — ...
